Index
S&P 500, RUI
Market Cap
20.59B
Enterprise Value
22.14B
Income
301.00M
Sales
7.06B
Book/sh
102.35
Cash/sh
12.52
Employees
15000
IPO
Sep 01, 2017
P/E
70.24
Forward P/E
19.01
PEG
0.90
P/S
2.92
P/B
1.52
P/C
12.41
P/FCF
25.61
EV/EBITDA
13.51
EV/Sales
3.14
Quick Ratio
1.74
Current Ratio
2.36
Debt/Eq
0.23
LT Debt/Eq
0.23
Option/Short
Yes / Yes
EPS (ttm)
2.21
EPS next Y
8.17
EPS next Q
1.92
EPS this Y
47.76%
EPS next Y
9.76%
EPS next 5Y
21.05%
EPS past 3/5Y
- 14.20%
Sales past 3/5Y
-19.27% -13.74%
EPS Y/Y TTM
140.39%
Sales Y/Y TTM
-43.45%
EPS Q/Q
203.37%
Sales Q/Q
-39.19%
Insider Own
0.37%
Insider Trans
-16.46%
Inst Own
82.30%
Inst Trans
-2.13%
ROA
1.32%
ROE
2.13%
ROIC
1.81%
Gross Margin
31.60%
Oper. Margin
14.39%
Profit Margin
4.26%
SMA20
11.01%
SMA50
15.96%
SMA200
11.68%
Trades
Shs Outstand
132.61M
Shs Float
132.04M
52W High
157.98 -1.65%
52W Low
111.15 39.78%
Volatility
4.80% 2.66%
ATR (14)
4.13
RSI (14)
71.89
Beta
1.03
Rel Volume
0.42
Avg Volume
1.10M
Volume
250,241
Perf Week
1.24%
Perf Month
20.10%
Perf Quarter
7.62%
Perf Half Y
2.47%
Perf YTD
28.83%
Perf Year
28.70%
Perf 3Y
80.14%
Perf 5Y
54.84%
Perf 10Y
-
Prev Close
155.14
Price
155.37
Change %
0.15%
Analysts 11 incl. previous ratings
Rating Distribution 8 Buy · 3 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Oct 13, 2026 Initiated B Barclays
Overweight $156 +0.4% Oct 09, 2026 Downgrade J JP Morgan
Overweight → Neutral $145 -6.7% Jun 15, 2026 Initiated G Goldman
Neutral $53 -65.9% Jul 03, 2025 Reiterated C Citigroup
Buy $75 → $85 -45.3% Apr 15, 2025 Upgrade B BofA Securities
Underperform → Neutral $75 -51.7% Apr 14, 2025 Upgrade K KeyBanc Capital Markets
Sector Weight → Overweight $81 -47.9% Feb 13, 2025 Upgrade B Barclays
Underweight → Equal Weight $85 → $89 -42.7% Jan 17, 2025 Upgrade W Wolfe Research
Peer Perform → Outperform $91 -41.4% Oct 07, 2024 Downgrade B Barclays
Equal Weight → Underweight $88 → $84 -45.9% May 28, 2024 Upgrade C Citigroup
Neutral → Buy $85 → $95 -38.9% May 24, 2024 Upgrade W Wells Fargo
Equal Weight → Overweight $80 → $103 -33.7% May 23, 2024 Upgrade B BMO Capital Markets
Market Perform → Outperform $96 -38.2% May 17, 2024 Upgrade J Jefferies
Hold → Buy $78 → $101 -35.0% Mar 01, 2024 Initiated W Wolfe Research
Peer Perform Jan 24, 2024 Downgrade W Wells Fargo
Overweight → Equal Weight $85 → $69 -55.6% Jan 24, 2024 Downgrade B BMO Capital Markets
Outperform → Market Perform $80 → $72 -53.7% Jan 16, 2024 Downgrade B BofA Securities
Buy → Underperform $78 → $80 -48.5% Jul 19, 2023 Reiterated C Citigroup
Neutral $72 → $75 -51.7% Jun 14, 2023 Initiated C Citigroup
Neutral $72 -53.7% May 15, 2023 Upgrade D Deutsche Bank
Hold → Buy $70 → $80 -48.5%
Show Previous Ratings
Nov-09-26 09:00AM
Nov-04-26 03:15PM
Nov-03-26 04:30PM
10:32AM
08:31AM
06:50AM
Loading…
06:50AM
06:22AM
(The Wall Street Journal)
06:00AM
Oct-29-26 09:00AM
Oct-26-26 04:35PM
Oct-22-26 09:00AM
Oct-15-26 10:14AM
Oct-13-26 04:30PM
01:00PM
Oct-09-26 09:45AM
07:00AM
Loading…
Oct-06-26 07:00AM
Oct-05-26 09:00AM
Oct-02-26 10:37AM
Oct-01-26 10:17AM
Sep-30-26 09:00AM
Sep-22-26 08:29AM
Sep-15-26 09:00AM
Sep-11-26 02:07PM
12:30PM
Sep-10-26 01:38PM
10:13AM
07:28AM
(The Wall Street Journal)
07:00AM
Aug-31-26 07:08AM
Aug-13-26 09:00AM
09:00AM
Loading…
Aug-11-26 09:00AM
Aug-06-26 01:00PM
Aug-05-26 04:30PM
11:00AM
09:00AM
Aug-04-26 03:01PM
08:25AM
07:36AM
06:25AM
(The Wall Street Journal)
06:00AM
Aug-03-26 05:27PM
Jul-20-26 05:52AM
Jul-16-26 09:13AM
Jul-15-26 09:00AM
Jul-14-26 07:00AM
Jul-09-26 01:59PM
(The Wall Street Journal)
01:26PM
08:00AM
Jul-08-26 01:36PM
01:07PM
Jun-24-26 04:30PM
02:52PM
Jun-10-26 09:00AM
Jun-09-26 09:00AM
May-26-26 05:18PM
04:48PM
(The Wall Street Journal)
04:15PM
May-23-26 08:23PM
May-21-26 09:00AM
May-12-26 09:45AM
06:33AM
May-08-26 09:00AM
May-05-26 08:01PM
04:15PM
02:13PM
11:27AM
07:44AM
07:15AM
06:47AM
06:14AM
(The Wall Street Journal)
06:00AM
12:31AM
May-04-26 08:00AM
Apr-23-26 09:00AM
Apr-21-26 09:00AM
08:00AM
Apr-17-26 09:00AM
Apr-16-26 07:00AM
Apr-15-26 04:30PM
Apr-14-26 09:00AM
Apr-09-26 09:00AM
Apr-07-26 09:00AM
Apr-01-26 07:45AM
07:32AM
Mar-30-26 09:00AM
Mar-26-26 09:00AM
Mar-18-26 05:51PM
(The Wall Street Journal)
04:30PM
Mar-12-26 05:01PM
07:25AM
Mar-11-26 09:00AM
08:49AM
Mar-10-26 08:00AM
Mar-05-26 10:12AM
Mar-04-26 07:04AM
Mar-03-26 09:00AM
04:37AM
Mar-02-26 07:51AM
Mar-01-26 11:08AM
Feb-27-26 01:53PM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Hoover Erik T. SVP & General Counsel Nov 09 '26 Option Exercise 108.84 4,203 457,455 43,001 Nov 09 05:41 PM Hoover Erik T. SVP & General Counsel Nov 09 '26 Sale 150.82 4,203 633,896 38,798 Nov 09 05:41 PM Koch Lori CEO Nov 09 '26 Option Exercise 108.84 2,311 251,529 118,026 Nov 09 05:41 PM Koch Lori CEO Nov 09 '26 Sale 151.15 2,311 349,308 115,715 Nov 09 05:41 PM BREEN EDWARD D Director Nov 05 '26 Option Exercise 108.84 89,845 9,778,730 217,121 Nov 09 05:21 PM BREEN EDWARD D Director Nov 05 '26 Sale 146.41 89,845 13,154,206 127,276 Nov 09 05:21 PM Koch Lori Officer Nov 09 '26 Proposed Sale 151.15 2,311 349,308 Nov 09 04:36 PM Hoover Erik T. Officer Nov 09 '26 Proposed Sale 150.82 4,203 633,897 Nov 09 04:34 PM BREEN EDWARD D Officer Nov 05 '26 Proposed Sale 146.42 89,845 13,154,896 Nov 05 04:08 PM Koch Lori CEO Jun 02 '26 Sale 48.82 261 12,741 0 Jun 02 06:54 PM Larrabee Steven P. Officer Jan 05 '26 Proposed Sale 41.48 1,922 79,725 Jan 05 04:30 PM Larrabee Steven P. Officer Dec 09 '25 Proposed Sale 41.04 72,958 2,993,941 Dec 09 04:29 PM Hoover Erik T. SVP & General Counsel Nov 28 '25 Option Exercise 28.00 6,005 168,140 118,106 Dec 01 04:58 PM Hoover Erik T. SVP & General Counsel Nov 28 '25 Sale 39.79 6,005 238,939 112,101 Dec 01 04:58 PM Koch Lori CEO Nov 28 '25 Option Exercise 28.00 9,011 252,308 297,337 Dec 01 04:57 PM Koch Lori CEO Nov 28 '25 Sale 39.46 9,011 355,574 288,326 Dec 01 04:57 PM Hoover Erik T. Officer Nov 28 '25 Proposed Sale 39.80 6,005 238,969 Nov 28 01:09 PM Koch Lori Officer Nov 28 '25 Proposed Sale 39.46 9,011 355,591 Nov 28 01:09 PM
DuPont de Nemours, Inc. engages in the development and manufacture of specialty materials and technology-based products. It operates through the Healthcare & Water Technologies and Diversified Industrials segments. The Healthcare & Water Technologies segment includes packaging, parts, and components for medical device and biopharma markets and water filtration and purification technologies primarily for industrial wastewater and energy, municipal drinking water and desalination, and life sciences and specialty markets. The Diversified Industrials segment builds technologies, with a portfolio serving new-build, repair, and remodel applications across non-residential and residential construction markets, and industrial technologies, which include a portfolio of adhesive, wear and friction, and packaging solutions serving aerospace, automotive, printing, and packaging markets. The company was founded in 1802 and is headquartered in Wilmington, DE.
CEO & Director Ms. Lori D. Koch
Senior VP & CFO Ms. Antonella B. Franzen
Senior VP & General Counsel Mr. Erik T. Hoover J.D.
Chief Human Resources Officer Mr. Christopher P. Raia
President of Healthcare & Water Technologies Mr. Jeroen Bloemhard